China SXT Pharmaceuticals, Inc.
SXTCAs of the close on Sep 25, 2026
Price
$2.57
Market cap
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
P/E (diluted TTM)
—
The last four quarters are not all on file
EPS (TTM)
—
The last four quarters are not all on file
Dividend yield
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How China SXT Pharmaceuticals, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: China SXT Pharmaceuticals, Inc. — 20-F filed Jul 31, 2025
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 10 annual periods. The latest annual period ends Mar 31, 2026.
Ownership
Ownership filing history is not available for this company.